COPD
Conference Coverage
Patients with moderate COPD also benefit from triple therapy
The benefits of triple-therapy seen in the ETHOS trial were not limited to patients with severe COPD, a subanalysis shows.
Conference Coverage
Sex differences in COPD symptoms predict cardiac comorbidity
“Our findings give hints how diagnostic information might be used differently in men and women.”
Conference Coverage
Worse outcomes for patients with COPD and COVID-19
From the Journals
Carbon monoxide diffusion with COPD declines more in women
Feature
Short-term oxygen prescriptions lead to inappropriate long-term use
Oxygen prescriptions at hospital discharge are a far more pernicious cause of wasted resources.
News
List of COVID-19 high-risk comorbidities expanded
Underlying conditions increase the risk of severe outcomes for patients infected with SARS-CoV-2.
From the Journals
New guidelines on antibiotic prescribing focus on shorter courses
From the Journals
Clinically important deterioration predicts poor future outcomes in COPD
Short-term changes are associated with longer-term outcomes.
From the Journals
Cannabinoids may pose death risk for older patients with COPD
All-cause mortality significantly increased in COPD patients aged 66 years and older after starting nabilone or dronabinol.
News
CDC: Vaccinated people can gather indoors without masks